-- 周四收盘时,伦敦富时100指数下跌0.05%,原因是以色列对黎巴嫩的空袭导致伊朗再次禁止油轮通过霍尔木兹海峡,这令外界对其与美国达成的停火协议产生怀疑。 丹麦银行表示:“伊朗和美国在关键问题上仍然存在巨大分歧,因此局势很可能再次升级。”伊朗议会议长穆罕默德·巴格尔·加利巴夫指出,停火协议的三项条款遭到违反。与此同时,美国总统唐纳德·特朗普在“真相社交”平台上发帖称,美军将坚守阵地,直到“真正的协议”得到全面遵守。他还补充说,如果协议得不到遵守,美军“实际上正在期待下一次征服”。 经济方面,英国皇家特许测量师学会发布的2026年3月房价指数为-23%,低于上月修正后的-14%。最新数据显示,市场预期降幅低于此前普遍预期的-18%,为2023年12月以来的最低水平。 “过去几个月,英国房地产市场的情绪发生了显著变化。此前谨慎好转的市场活动,因中东冲突带来的更广泛的宏观经济影响而偏离轨道,抵押贷款利率前景的再次恶化尤其具有挑战性。……未来走向取决于近期油价和能源成本的飙升能否在当前高度不确定的地缘政治环境下开始逆转,”皇家特许测量师学会(RICS)市场研究与分析主管塔兰特·帕森斯(Tarrant Parsons)表示。 “3月份的调查数据显示,英国上市房屋建筑商的短期前景无疑为负面。购房需求的急剧恶化、近期销售预期暴跌(至-33%)以及价格下行压力的加剧,都预示着2026年第二季度将面临更加严峻的交易环境,”加拿大皇家银行资本市场(RBC Capital Markets)表示。 企业新闻方面,伦敦证券交易所集团(LSEG.L)宣布启动一项价值高达9亿英镑的股票回购计划,消息公布后股价上涨0.18%。 与此同时,英美烟草公司(BATS.L)股价下跌1.99%,宣布任命德拉戈斯·康斯坦丁内斯库(Dragos Constantinescu)为首席财务官,该任命将于9月1日生效。在此之前,贾韦德·伊克巴尔(Javed Iqbal)将继续担任这家烟草和尼古丁产品巨头的临时首席财务官。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.